Latent tuberculosis infection: old problem, new priorities - sprookjes - yvandenbroek - TriplyDB

Latent tuberculosis infection: old problem, new priorities

Latent tuberculosis infection: old problem, new priorities

http://www.wikidata.org/entity/Q34594825

about

Adverse events associated with treatment of latent tuberculosis in the general population.Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary.Latent tuberculosis treatment.Latent tuberculosis treatment.

P2860

Q34589993-E22A46BD-FEE2-4C13-9401-D8DAA1722663 Q39758585-371A3429-B52A-43C3-9CEB-3259430B231C Q42771659-B434F832-2C18-405C-A421-2092DDD4BDAA Q50424858-AD515A79-C6F5-45E7-8CB5-21E81E28F175

P2860

Latent tuberculosis infection: old problem, new priorities

http://www.wikidata.org/entity/Q34594825

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Latent tuberculosis infection: old problem, new priorities

@ast

Latent tuberculosis infection: old problem, new priorities

@en

Latent tuberculosis infection: old problem, new priorities

@nl

type

label

Latent tuberculosis infection: old problem, new priorities

@ast

Latent tuberculosis infection: old problem, new priorities

@en

Latent tuberculosis infection: old problem, new priorities

@nl

prefLabel

Latent tuberculosis infection: old problem, new priorities

@ast

Latent tuberculosis infection: old problem, new priorities

@en

Latent tuberculosis infection: old problem, new priorities

@nl

P1433

Q34594825-BCE296C4-8A6C-4621-A587-DD6E95190DEA

P1476

Q34594825-441076C9-4805-412D-8B38-028BD4C9189D

P2093

Q34594825-CF853CF8-A36B-4222-92E9-CFDCBA4D9A38

P2860

Q34594825-022F3F2B-1414-43E0-9E13-BE98A99F3B84

Q34594825-162E7A71-64E9-4C75-80C3-626A30E3EFC4

Q34594825-211EB3F2-BDB3-4253-934D-0274345AFDA1

Q34594825-3FA95BD5-5AC3-4404-903E-F4FC25EF59EE

Q34594825-5B465305-75EA-4B94-9858-7D1F0C95274F

Q34594825-7A1E9FE4-6345-4DAF-B0DA-685932964339

Q34594825-849B8595-4BBB-4B27-9A6C-3B305BF9D755

Q34594825-9C90DF66-C7B9-4F08-A711-37E3D347C2ED

Q34594825-9E7B9E39-A797-4BBF-820D-C601E20764DB

Q34594825-A312C641-0F97-41C6-8BC8-166D657EBAB5

P304

Q34594825-63779ABB-A26B-411C-B1DC-2CD6DE513449

P31

Q34594825-60A06B68-226B-4D31-84E7-835320C7C322

P407

Q34594825-05B29EA2-1137-4028-8E50-522079040BC9

P433

Q34594825-BF97165C-4CD1-4F14-AECA-A3F6225D6C38

P478

Q34594825-3E7650AD-90DD-471D-88F9-5089B21B2754

P577

Q34594825-1DEA1828-989B-4533-84DD-D7DD5BA36C3B

P698

Q34594825-C1AD5BCC-E582-4287-A5CF-535CB7D38742

P921

Q34594825-C4215399-B3E9-49B3-89E2-354A6866911F

P932

Q34594825-8F89B877-E428-4DE5-B0F1-08737F832180

P1433

Canadian Medical Association Journal

P1476

Latent tuberculosis infection: old problem, new priorities

@en

P2093

Kevin Schwartzman

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?

Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.

Tuberculosis in New York City--turning the tide.

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.

Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area.

Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.

A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997.

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.

P304

759-761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11944762

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

99454

http://www.w3.org/2001/XMLSchema#string